1. Home
  2. ULCC vs RAPP Comparison

ULCC vs RAPP Comparison

Compare ULCC & RAPP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Frontier Group Holdings Inc.

ULCC

Frontier Group Holdings Inc.

HOLD

Current Price

$4.90

Market Cap

1.1B

ML Signal

HOLD

RAPP

Rapport Therapeutics Inc.

HOLD

Current Price

$30.85

Market Cap

1.2B

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
ULCC
RAPP
Founded
1994
2022
Country
United States
United States
Employees
N/A
N/A
Industry
Air Freight/Delivery Services
Sector
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.2B
IPO Year
2021
2024

Fundamental Metrics

Financial Performance
Metric
ULCC
RAPP
Price
$4.90
$30.85
Analyst Decision
Hold
Strong Buy
Analyst Count
10
5
Target Price
$5.56
$47.80
AVG Volume (30 Days)
5.1M
381.6K
Earning Date
02-06-2026
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$3,729,000,000.00
N/A
Revenue This Year
$0.37
N/A
Revenue Next Year
$14.59
N/A
P/E Ratio
N/A
N/A
Revenue Growth
1.77
N/A
52 Week Low
$2.89
$6.43
52 Week High
$10.26
$42.27

Technical Indicators

Market Signals
Indicator
ULCC
RAPP
Relative Strength Index (RSI) 50.71 59.91
Support Level $4.89 $28.03
Resistance Level $5.57 $31.52
Average True Range (ATR) 0.36 1.97
MACD -0.06 0.06
Stochastic Oscillator 25.00 85.33

Price Performance

Historical Comparison
ULCC
RAPP

About ULCC Frontier Group Holdings Inc.

Frontier Group Holdings Inc is an ultra-low-cost carrier whose business is focused on Low Fares Done Right. The company owns a fleet of 120 Airbus single-aisle aircraft, consisting of 13 A320ceos, 82 A320neos, 21 A321ceos and 4 A321neos. The use of these aircraft, their seating configuration, weight-saving tactics, and baggage process have all contributed to the ability to continue to be the fuel-efficient of all the U.S. The Company is managed as a single business unit that provides air transportation for passengers. Majority of revenue is from Domestic flight follow by International.

About RAPP Rapport Therapeutics Inc.

Rapport Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovery and development of transformational small-molecule medicines for patients suffering from central nervous system disorders. Its foundational science has elucidated the complexities of neuronal receptor biology and enables the company to map and target certain neuronal receptor complexes. Neuronal receptors are complex assemblies of proteins, comprising receptor principal subunits and their receptor-associated proteins (RAPs), the latter of which play crucial roles in regulating receptor expression and function.

Share on Social Networks: